Minimal sex-differential modulation of reactivity to pathogens and toll-like receptor ligands following infant Bacillus Calmette–Guérin Russia vaccination
Bacillus Calmette–Guérin (BCG), the only licensed vaccine against tuberculosis, has been shown to provide heterologous protection against unrelated pathogens and enhance antibody responses to several routine expanded program on immunization (EPI) vaccines. Understanding these heterologous effects is...
Päätekijät: | Darboe, F, Adetifa, JU, Reynolds, J, Hossin, S, Plebanski, M, Netea, MG, Rowland-Jones, SL, Sutherland, JS, Flanagan, KL |
---|---|
Aineistotyyppi: | Journal article |
Julkaistu: |
Frontiers Media
2017
|
Samankaltaisia teoksia
-
Minimal Sex-Differential Modulation of Reactivity to Pathogens and Toll-Like Receptor Ligands following Infant Bacillus Calmette–Guérin Russia Vaccination
Tekijä: Fatoumatta Darboe, et al.
Julkaistu: (2017-09-01) -
Reiter's syndrome postintravesical Bacillus Calmette–Guérin instillations
Tekijä: Ng, K.L., et al.
Julkaistu: (2017) -
Bacillus Calmette–Guérin Immunotherapy for Cancer
Tekijä: Fabíola Cardillo, et al.
Julkaistu: (2021-05-01) -
Bacillus Calmette–Guérin and Bladder Cancer
Tekijä: Azad H.A. Razack
Julkaistu: (2007-10-01) -
Hepatitis in Disseminated Bacillus Calmette-Guérin Infection
Tekijä: Markus U Göttke, et al.
Julkaistu: (2000-01-01)